Catamaran Corp (USA)  

(Public, NASDAQ:CTRX)   Watch this stock  
Find more results for NASDAQ:SXCI
51.83
+0.15 (0.28%)
Dec 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 51.42 - 52.00
52 week 36.98 - 52.98
Open 51.92
Vol / Avg. 469,848.00/994,542.00
Mkt cap 10.72B
P/E 36.90
Div/yield     -
EPS 1.40
Shares 207.48M
Beta 0.15
Inst. own 87%
Feb 25, 2015
Q4 2014 Catamaran Corp Earnings Release (Estimated) - 6:00AM EST - Add to calendar
Dec 3, 2014
Catamaran Corp at Bank of America Merrill Lynch Leveraged Finance Conference
Nov 12, 2014
Catamaran Corp at Credit Suisse Healthcare Conference
Oct 30, 2014
Q3 2014 Catamaran Corp Earnings Call
Oct 30, 2014
Q3 2014 Catamaran Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 1.74% 2.02%
Operating margin 2.67% 3.00%
EBITD margin - 4.66%
Return on average assets 4.20% 3.88%
Return on average equity 6.43% 5.51%
Employees 4,000 -
CDP Score - -

Address

1600 MCCONNOR PARKWAY
SCHAUMBURG, IL 60173-6801
United States - Map
+1-800-2823232 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Catamaran Corporation (Catamaran), formerly SXC Health Solutions Corp. is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company�s PBM services are marketed under the Catamaran PBM brand, includes electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, and reporting and information analysis. Its HCIT solutions include: RxCLAIM, an on-line transaction processing system that provides instant adjudication of prescription drug claims; RxMAX, rebate management system; RxTRACK, data warehouse and analysis system, and Zynchros, formulary management tools. Its customers include organizations in the pharmaceutical supply chain.

Officers and directors

Mark A. Thierer Chairman of the Board, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Mike Shapiro Chief Financial Officer, Senior Vice President
Age: 43
Bio & Compensation  - Reuters
Jeffrey Park Executive Vice President - Operations
Age: 42
Bio & Compensation  - Reuters
John Romza Executive Vice President - Quality and Innovation
Age: 58
Bio & Compensation  - Reuters
Joel Saban Executive Vice President - Pharmacy Operations
Age: 46
Bio & Compensation  - Reuters
Clifford E. Berman Senior Vice President, General Counsel, Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Steven D. Cosler Lead Independent Director
Age: 58
Bio & Compensation  - Reuters
Peter J. Bensen Independent Director
Age: 51
Bio & Compensation  - Reuters
William J. Davis Independent Director
Age: 46
Bio & Compensation  - Reuters
Steven B. Epstein J.D. Independent Director
Age: 70
Bio & Compensation  - Reuters